OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Mario Germano Giuliani and Lisa Giuliani Gift $27.8 Million for Multiple Myeloma Research

Stage I TNBC Is Not One Risk Group: Can Immune Biology Identify Patients Who Need Less Treatment?

TG4050 Neoantigen Vaccine Shows 100% Three-Year Disease-Free Survival in Phase 1 Head and Neck Cancer Trial

Exercise in Lung Cancer Care: From Supportive Evidence to Global Implementation With IREX-Lung

Joakim Dillner: The Elimination of HPV and Cervical Cancer is Approaching the End Game

Oncology News, Insights, Stories by OncoDaily

Thomas E. Stinchcombe
Career Updates

Thomas E. Stinchcombe Named New Editor-in-Chief of Journal of Clinical Oncology

King Hussein Cancer
Societies

King Hussein Cancer Center Launches Survey to Strengthen Collaborative Oncology Research in the Arab World

Al-Ola A Abdallah
Voices

Al-Ola Abdallah: The Price of Publishing Science is Skyrocketing

King Hussein Cancer Center Launches Survey to Strengthen Collaborative Oncology Research in the Arab World

Sacrificing the Future to Save the Present: Intergenerational Financial Toxicity and Treatment Abandonment in Tunisia

Thomas E. Stinchcombe Named New Editor-in-Chief of Journal of Clinical Oncology

Tommy John and Bladder Cancer: The Inspiring Story of a Baseball Legend Who Changed Sports Medicine

E. Anders Kolb: Nearly 26 Million Years of Life Saved Through Blood Cancer Advances

Applying Metastatic Renal Cell Carcinoma Guidelines Across Resource Settings: From Recommendations to Deliverable Care

Al-Ola Abdallah: The Price of Publishing Science is Skyrocketing

Voices
School of Medicine, Trinity College Dublin

Introduction of New Year Two Curriculum - School of Medicine, Trinity College Dublin

CancerX Accelerator: A Growth Story for Oncology Startups - CancerX

Exciting News for Emerging Leaders in Clinical Biomedical Research! - The National Institutes of Health

Mitchell Elliott։ Longitudinal ctDNA Tracking in Early and Recurrent Breast Cancer

Ioanna Nixon: Growing Older Is a Privilege, Making Every Day Count

Zainab Shinkafi-Bagudu Connecting Leaders, Nurses and Advocates to Advance Cancer Care

Sandra Turner Looks Ahead to the Future of World Radiotherapy Awareness Day

FDA Approvals
Ziihera

FDA Approves Ziihera With and Without Tislelizumab Plus Chemotherapy for First-Line HER2-Positive Gastroesophageal Adenocarcinoma

FDA Approves OncoSil Device for Distal Cholangiocarcinoma

FDA Grants Accelerated Approval to Bristol Myers Squibb’s Zenbexus Plus Daratumumab and Hyaluronidase-fihj and Dexamethasone for Multiple Myeloma

FDA Grants Priority Review to RYBREVANT FASPRO After Promising 42% Response in Head and Neck Cancer

FDA Approved Subcutaneous Isatuximab: Advancing Anti-CD38 Therapy Delivery in Multiple Myeloma

FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approved Decnupaz, the First ADC for Adults With BPDCN

OncoDaily 100
100 Influential Women in Oncology

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential People in Oncology 2026 – Nominations are Open!

100 Influential Cancer Survivors on Social Media: 2026 Edition

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

Celebrities and Cancer

OncoCalendar

ESMO Preceptorship on Prostate Cancer 2027

European Society For Medical Oncology (ESMO)

13 Jan
Preceptorship on Prostate Cancer

European Women Cancer Assembly 2026

Women Cancer Europe

28 Sep
Women Cancer Assembly

70th IAEA General Conference

International Atomic Energy Agency

14 Sep
IAEA General Conference

ESMO Advanced Course on Endocrine Sensitivity in HR+/HER2− Metastatic Breast Cancer 2026

European Society For Medical Oncology (ESMO)

25 Nov
Endocrine Sensitivity

2026 Advances in Chronic Graft-Versus-Host Disease

Memorial Sloan Kettering Cancer Center (MSK)

30 Oct
Graft-Versus-Host Disease

Immune-oncology
RATIONALE-306: Tislelizumab Plus Chemotherapy Shows Sustained 3-Year Survival Benefit in Advanced ESCC

RATIONALE-306: Tislelizumab Plus Chemotherapy Shows Sustained 3-Year Survival Benefit in Advanced ESCC

Etentamig and the Next Wave of Immune Engagers in Multiple Myeloma

Dana-Farber Study Links CDK2 Activity With Response to Immune Checkpoint Blockade

Talquetamab in R/R Multiple Myeloma: Real-World Analysis From the IMWG Immunotherapy Registry

What Happens If CAR T-Cell Therapy Fails? Relapse, Refractory Disease, and Next Treatment Options

Anti-CD7 CAR T-Cell Therapy Shows Promising CNS Activity in Relapsed or Refractory T-ALL/LBL

ctDNA and MRD in NSCLC: Emerging Clinical Applications in the Immunotherapy Era

Gastrointestinal-Oncology
Esophageal Adenocarcinoma Biomarkers: HER2, PD-L1, MSI, CLDN18.2 and Emerging Targets

Esophageal Adenocarcinoma Biomarkers: HER2, PD-L1, MSI, CLDN18.2 and Emerging Targets

Esophageal Squamous Cell Carcinoma Biomarkers: PD-L1, Molecular Features and Emerging Targets

Ziihera Plus Chemotherapy Improves Overall Survival in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma

Phase 2 NEST Trial: Neoadjuvant BOT/BAL in Localized Colon Cancer

FDA Approves Daraxonrasib: First-in-Class RAS Inhibitor for Metastatic Pancreatic Cancer

SKYSCRAPER-07: Atezolizumab ± Tiragolumab After dCRT in Unresectable ESCC

TALENTOP: Liver Resection After Atezolizumab and Bevacizumab in Locally Advanced HCC

Breast-Oncology
Camizestrant

FDA Grants Accelerated Approval to Camizestrant for ESR1-Mutated Advanced Breast Cancer

Stage I TNBC Is Not One Risk Group: Can Immune Biology Identify Patients Who Need Less Treatment?

When Bone-Only HR+/HER2− Breast Cancer Turns Visceral: What PR Expression May Tell Us in the CDK4/6 Era

Enhertu Plus Pertuzumab Approved in the EU for First-Line HER2-Positive Metastatic Breast Cancer: A New Benchmark After More Than a Decade

Trastuzumab deruxtecan Plus Pertuzumab Approved in EU for First-Line HER2-Positive Metastatic Breast Cancer

Iza-Bren Reaches the Phase III PFS Endpoint in HR+/HER2− Advanced Breast Cancer: Why PANKU-Breast01 Matters

ctDNA During Neoadjuvant Therapy: Toward Real-Time Risk Stratification in Early Breast Cancer

Lung-Oncology
Lung Cancer

Exercise in Lung Cancer Care: From Supportive Evidence to Global Implementation With IREX-Lung

Daraxonrasib Opens a Broader RAS-Targeting Strategy in Previously Treated NSCLC

SANOVO: Osimertinib Plus Savolitinib Moves MET-Directed Therapy Into First-Line EGFR-Mutated NSCLC

XPO1 Inhibition May Reprogram Immune Resistance in SCLC: The TRIM21–IRF3–TNFSF15–TREM2 Axis

AstraZeneca Completes Zegfrovy Deal for EGFR Exon 20 Insertion NSCLC

Adjuvant Crizotinib Fails in Resected ALK-Positive NSCLC: What E4512 Tells Us About Targeted Therapy in Early Disease

7 Powerful Advances in the ASCO 2026 Guideline for Driver-Positive Stage IV NSCLC

OncoDaily TV
Treatment Paradigms, Karine Tawagi

Evolving Treatment Paradigms in Muscle-Invasive Bladder Cancer

Cancer in Women

Cancer in Women As a Global Health and Economic Issue: Dr. Maira Caleffi

oncoffee, palliative

ONCOFFEE: Colorectal Cancer, Palliative Care, and the Human Side of Oncology: Santiago Fontes

Empowering Oncologists

Empowering Oncologists: How Policy impacts Medicine?

WHO

Mission is possible: WHO said 2030 – Rwanda said 2027: Dr. Sabin Nsanzimana

Current Landscape

The Current Landscape and Future of CAR-T in Aggressive B-Cell Lymphoma

Experts by Experience

Experts by Experience with Carmen Monge

Fighting Cervical Cancer

From Engineering to Fighting Cervical Cancer

Dr. Beatrice Addai Wiafe

Fighting Cancer With Peace And Love: Dr. Beatrice Addai Wiafe

Maggie Smith breast cancer

Dame Maggie Smith and Courageus Breast Cancer Journey: Filming Harry Potter During Chemotherapy

Petra Jankowska

Leading with Humanity in Modern Oncology: Dr. Petra Jankowska

Princess Dina

Episode 18: Global Health Dialogues with Princess Dina and Dr Urvi Shah

Not To Miss
Gevorg Tamamyan

OncoDaily Editor-in-Chief Gevorg Tamamyan Awarded 2026 Global Health Catalyst Distinguished Leader Award

Highlights From LeukO 2026: Global Virtual Congress on Leukemias, Day 2

FDA Grants Accelerated Approval to Camizestrant for ESR1-Mutated Advanced Breast Cancer

TG4050 Neoantigen Vaccine Shows 100% Three-Year Disease-Free Survival in Phase 1 Head and Neck Cancer Trial

Highlights From LeukO 2026: Global Virtual Congress on Leukemias, Day 1

Etentamig Improves Response Rate and PFS in Phase 3 CERVINO Multiple Myeloma Trial

HUTCHMED and GSK Sign Up to $1.295B Licensing Deal for KRAS-EGFR Cancer Therapy HMPL-A830

OncoGrants
Glioblastoma Therapeutics

NCI Glioblastoma Therapeutics Network U19 Grant 2026

CRI

CRI Irvington Postdoctoral Cancer Research Fellowship (March 2027 Cycle)

Pathway to Independence Award

NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers 2026

Metastasis Research Network

NCI Metastasis Research Network U54 Grant 2026

NCI

NCI Academic–Industrial Partnerships for Cancer Imaging R01 Grant 2026

McCaskill-Stevens Career Development

NCI Worta McCaskill-Stevens Career Development Award 2027

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

CancerWorld

Oncologists
Dinesh Pendharkar

Dinesh Pendharkar

Oncologists Location Faridabad, India
Lucia Masarova

Lucia Masarova

Oncologists Location Houston, USA
Tetiana Shevchuk

Tetiana Shevchuk

Oncologists Location Kyiv, Ukraine
Rawad Rihani

Rawad Rihani

Oncologists Location Amman, Jordan
Shubha De Sarkar

Shubha De Sarkar

Oncologists Location Jaipur, India
Dario Trapani

Dario Trapani

Oncologists Location Milan, Italy
Eric Van Cutsem

Eric Van Cutsem

Oncologists Location Leuven, Belgium
Leo Mascarenhas

Leo Mascarenhas

Oncologists Location Los Angeles, USA

Oncology Drugs
OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

mRNA-4359: Promising Cancer Vaccine, Dose, Administration, and Clinical Trials

BXCL701: Promising Innate Immune Activation, Dose, Administration, And Clinical Trials

NBTXR3: Promising Radioenhancer, Administration, Dose, And Clinical Trials

KT-333: Promising STAT3 Degradation, Dose, Administration, And Clinical Trials

Veliparib: Mechanism, Dose, Administration, And Clinical Trials

Adavosertib: Mechanism, Dose, Administration, And Clinical Trials

OncoDaily Magazine

New Paper Alert
Wen Jiang

Wen Jiang: Translational Challenges and Opportunities in mRNA Cancer Vaccines

Victor Moreno

Victor Moreno: Rethinking What Phase 1 Means in Modern Oncology Trials

Rik Bryan

Rik Bryan: New Data Highlight the Potential of the GALEAS Bladder Test

Erika Hamilton

Erika Hamilton: Addressing Depression and Stress in Cancer Survivors

Mahmoud Gaballa

Mahmoud Gaballa: New Insights Into Bispecific Antibodies in Plasma Cell Leukemia

Dana-Farber Cancer Institute

Dana-Farber Study Links CDK2 Activity With Response to Immune Checkpoint Blockade

OncoDaily Medical Journal

Pediatric Oncology

10.69690/ODMJ-011-0826-7849

Integrated Management of Endo and Exo-pelvic Sacrococcygeal Teratomas (Altman type III): Report of Two Cases
Case Reports & Case Series

GI Oncology

10.69690/ODMJ-018-0826-7959

From Plate to Polyps: Dietary N-Nitrosamines and Biomarkers of DNA Damage
Abstracts

Head and Neck Cancer

10.69690/ODMJ-018-0826-7933

A Service Review of PD-L1 Biomarker Use in the Head and Neck Cancer Service
Abstracts

Radiation Oncology

10.69690/ODMJ-018-0826-7920

Short-Course Palliative Radiotherapy for Tumour-Related Bleeding in End-of-Life Care: A Focused Literature Review
Abstracts

Pediatric Oncology

10.69690/ODMJ-018-0826-7952

FLASH radiotherapy: A Potential Way to Protect the Developing Brain in Pediatric Oncology
Abstracts

GI Oncology

10.69690/ODMJ-018-0826-7947

Real World Clinical Insights in Combination of Trifluridine-Tipiracil with Bevacizumab for Metastatic Colorectal Cancer
Abstracts

Hematology

10.69690/ODMJ-018-0826-7945

Plasma cell survival: The impact of extracellular ATP
Abstracts

Breast Cancer

10.69690/ODMJ-018-0826-7965

A Systematic Comparison of ICG Fluorescence vs Dual-Tracer Sentinel Lymph Node Biopsy in Breast Cancer Staging
Abstracts